BFC
FLGT icon

Bedel Financial Consulting’s Fulgent Genetics FLGT Stock Holding History

Bedel Financial Consulting’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-117
Closed -$7K – 424
2022
Q1 		$7K Buy
117
+17
+17% +$1.12K ﹤0.01% 723
2021
Q4 		$10K Hold
100
– – ﹤0.01% 682
2021
Q3 		$9K Buy
+100
New +$9.09K ﹤0.01% 686

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bedel Financial Consulting's FLGT Position: Q2 2022 in Review

Bedel Financial Consulting sold out of Fulgent Genetics (FLGT) in Q2 2022, closing a stake of 117 shares — an estimated $7K sold.

Bedel Financial Consulting first reported a position in FLGT in Q3 2021 and held it in 3 quarters. The position peaked at $10K in Q4 2021. 262 funds tracked by Wall St. Rank hold FLGT as of Q2 2022.

  • Bedel Financial Consulting reported no remaining Fulgent Genetics position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 117 Fulgent Genetics shares in Q2 2022, an estimated $7K.
  • Bedel Financial Consulting first reported a position in Fulgent Genetics in Q3 2021 and held it in 3 quarters.
  • Bedel Financial Consulting's Fulgent Genetics position peaked at $10K in Q4 2021.
  • 262 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.